Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


12.09.2022

3 Biochem Biophys Res Commun
1 BMC Gastroenterol
1 Cancer Res
2 Dig Dis
4 Hepatology
1 J Gastroenterol Hepatol
5 J Hepatol
1 J Pediatr
1 Oncogene
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
1 Semin Liver Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. LEE KM, Hwang YJ, Jung GS
    Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression.
    Biochem Biophys Res Commun. 2022;626:135-141.
    PubMed         Abstract available

  2. TIAN-QI C, Yan-Fang D, Yan-Yan W, Yong-Hui Z, et al
    Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-kappaB signaling pathway.
    Biochem Biophys Res Commun. 2022;626:167-174.
    PubMed         Abstract available

  3. LIN C, Yang H, Zhao W, Wang W, et al
    CTSB(+) macrophage repress memory immune hub in the liver metastasis site of colorectal cancer patient revealed by multi-omics analysis.
    Biochem Biophys Res Commun. 2022;626:8-14.
    PubMed         Abstract available


    BMC Gastroenterol

  4. ALSHUWAYKH O, Cheung A, Goel A, Kwong A, et al
    Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
    BMC Gastroenterol. 2022;22:410.
    PubMed         Abstract available


    Cancer Res

  5. HU B, Zou T, Qin W, Shen X, et al
    Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma.
    Cancer Res. 2022 Sep 6. pii: 708982. doi: 10.1158/0008-5472.CAN-21-4140.
    PubMed         Abstract available


    Dig Dis

  6. KALAL CR, Maiwall R, Choudhary A, Premkumar M, et al
    Mannitol Is Comparable to Hypertonic Saline for Raised Intracranial Pressure in Acute Liver Failure (MAHAL Study): A Randomized Controlled Trial.
    Dig Dis. 2022;40:607-615.
    PubMed         Abstract available

  7. LEMMER P, Selbach N, Baars T, Porsch-Ozcurumez M, et al
    Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm.
    Dig Dis. 2022;40:644-653.
    PubMed         Abstract available


    Hepatology


  8. Retracted: Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
    Hepatology. 2022 Sep 8. doi: 10.1002/hep.32736.
    PubMed        

  9. DUAN Z
    Postvaccination COVID-19 related mortality in patients with cirrhosis:who is the culprit?
    Hepatology. 2022 Sep 5. doi: 10.1002/hep.32750.
    PubMed        

  10. HUANG H, Wu L, Lu L, Zhang Z, et al
    Single-cell Transcriptomics Uncovers Cellular Architecture and Developmental Trajectories in Hepatoblastoma.
    Hepatology. 2022 Sep 4. doi: 10.1002/hep.32775.
    PubMed         Abstract available

  11. KNORR J, Kaufmann B, Inzaugarat ME, Holtmann TM, et al
    Interleukin-18 signaling promotes activation of hepatic stellate cells in murine liver fibrosis.
    Hepatology. 2022 Sep 4. doi: 10.1002/hep.32776.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  12. ZHANG C, Dai D, Zhang W, Yang W, et al
    Role of m6A RNA methylation in the development of hepatitis B virus-associated hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2022 Sep 6. doi: 10.1111/jgh.15999.
    PubMed         Abstract available


    J Hepatol

  13. BASELLI G, Romeo S, Valenti L
    Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiers.
    J Hepatol. 2022 Aug 17. pii: S0168-8278(22)02992.
    PubMed        

  14. SEMMLER G, Lens S, Meyer EL, Baiges A, et al
    Non-invasive tests for clinically significant portal hypertension after HCV cure.
    J Hepatol. 2022 Sep 2. pii: S0168-8278(22)03056.
    PubMed         Abstract available

  15. YANG H, Bae SH, Jang JW
    Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: considerations'.
    J Hepatol. 2022 Sep 1. pii: S0168-8278(22)03057.
    PubMed        

  16. BAIGES A, Procopet B, Silva-Junior G, Llop E, et al
    Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.
    J Hepatol. 2022 Sep 1. pii: S0168-8278(22)03054.
    PubMed         Abstract available

  17. PATERNOSTRO R, Kwanten WJ, Reiberger T
    Portal hypertension is a key determinant of the risk for liver-related events in non-alcoholic fatty liver disease.
    J Hepatol. 2022 Sep 4. pii: S0168-8278(22)03062.
    PubMed        


    J Pediatr

  18. ROGERS ME, Balistreri WF
    50 Years Ago in TheJournalofPediatrics: Hepatic Dysfunction Post-Kidney Transplant.
    J Pediatr. 2022;247:137.
    PubMed        


    Oncogene

  19. CHAND V, Liao X, Guzman G, Benevolenskaya E, et al
    Correction: Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.
    Oncogene. 2022 Sep 7. pii: 10.1038/s41388-022-02436.
    PubMed        


    PLoS One

  20. KARMACHARYA MB, Hada B, Park SR, Kim KH, et al
    Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats.
    PLoS One. 2022;17:e0274126.
    PubMed         Abstract available

  21. NASERALALLAH LM, Aboujabal BA, Geryo NM, Al Boinin A, et al
    The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.
    PLoS One. 2022;17:e0268705.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. YAMADA K, Motohashi S, Oikawa T, Tago N, et al
    Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer.
    Proc Natl Acad Sci U S A. 2022;119:e2202730119.
    PubMed         Abstract available


    Radiology

  23. GHELFI J, Decaens T, Macek Jilkova Z
    Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization.
    Radiology. 2022 Sep 6:220179. doi: 10.1148/radiol.220179.
    PubMed        


    Semin Liver Dis

  24. NEVENS F, van der Merwe S
    Mesenchymal Stem Cell Transplantation in Liver Diseases.
    Semin Liver Dis. 2022;42:283-292.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: